Janux Therapeutics Ratios (2020-2026) | JANX

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-1,287.55%-928.90%-830.20%-843.93%-714.08%-920.90%-564.67%-852.49%-1,656.39%-459.59%-477.77%-1,178.91%-66.98%-6,391.57%-243.13%-652.59%
EBIT Margin (Quarter)
-1,297.10%-940.72%-834.78%-852.23%-729.85%-994.04%-642.04%-990.28%-1,962.91%-628.25%-655.71%-1,610.30%-155.36%-8,164.46%-352.51%-916.50%
EBITDA Margin (Quarter)
-1,284.02%-928.30%-848.39%-942.54%-728.46%-941.31%-538.59%-813.62%-1,686.75%-464.16%-403.01%-1,273.88%-79.25%-4,239.64%-234.98%-752.77%
Operating Margin (Quarter)
-1,297.10%-940.72%-834.78%-852.23%-729.85%-994.04%-642.04%-990.28%-1,962.91%-628.25%-655.71%-1,610.30%-155.36%-8,164.46%-352.51%-916.50%
Net Margin (Quarter)
-1,287.55%-928.90%-830.20%-843.93%-714.08%-920.90%-564.67%-852.49%-1,656.39%-459.59%-477.77%-1,178.91%-66.98%-6,391.57%-243.13%-652.59%
FCF Margin (Quarter)
-1,286.31%-531.75%-721.16%-750.03%-319.07%-878.87%-491.00%-693.16%-1,440.78%-464.00%-390.21%-1,185.06%-115.92%-451.25%-121.13%-337.80%
Efficiency
Assets Average (Quarter)
393.95M385.45M374.21M376.98M380.56M369.88M358.48M347.23M364.18M383.63M534.70M690.20M693.22M878.27M1,056.14M1,041.49M1,028.49M1,013.17M1,014.89M
Equity Average (Quarter)
184.01M380.77M371.54M361.20M349.95M337.66M326.13M316.00M305.37M324.21M346.65M500.06M656.72M656.89M839.44M1,017.62M1,001.49M983.54M966.69M949.18M
Invested Capital (Quarter)
384.80M376.75M366.33M356.08M343.81M331.51M320.74M311.26M299.47M348.95M344.35M655.76M657.68M656.10M1,022.78M1,012.47M990.52M976.55M956.82M941.53M
Asset Utilization Ratio (Quarter)
0.010.010.010.020.020.020.030.020.020.020.010.020.020.010.010.000.010.010.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Equity Ratio (Quarter)
0.970.960.960.970.890.880.880.880.880.900.910.950.950.940.960.960.960.950.960.92
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)
-394.19M-696.24M-374.96M-361.20M-354.30M-338.76M-327.02M-316.88M-303.29M-349.71M-344.03M-651.76M-646.29M-658.03M-1025.17M-1014.15M-996.01M-988.99M-966.57M-956.39M
Return Ratios
Return on Sales (Quarter)
-0.13%-0.09%-0.08%-0.08%-0.07%-0.09%-0.06%-0.09%-0.17%-0.05%-0.05%-0.12%-0.01%-0.64%-0.07%-0.08%-2.41%-0.02%-0.11%-0.07%
Return on Capital Employed (Quarter)
-5.53%-8.84%-12.22%-15.16%-17.11%-18.99%-21.56%-23.48%-21.48%-19.69%-13.90%-9.72%-12.72%-11.48%-10.94%-14.20%-14.42%-15.96%-16.42%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%